| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 658543 | 68503 | CAPTOR SIMPLEX 200 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | CAPTOR SIMPLEX 200 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 60 cápsulas | 200 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68503/68503_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68503/68503_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | FERRER INTERNACIONAL S.A. | 2007-02-22 | 1 | 1 | 1 | 2007-02-22 | 2007-02-22 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660209 | 62086 | GINEDERMOFIX 500 MG COMPRIMIDO VAGINAL | GINEDERMOFIX 500 MG COMPRIMIDO VAGINAL, 1 comprimido | 500 mg | 5 | 1 | 11 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62086/62086_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62086/62086_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | FERRER INTERNACIONAL S.A. | 1998-07-01 | 1 | 1 | 1 | 1998-07-01 | 1998-07-01 | 0 | 2011-03-18 | View Edit Delete | ||||||||||||
| 658668 | 68570 | ADOLONTA RETARD 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA | ADOLONTA RETARD 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA , 20 comprimidos | 50 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68570/68570_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68570/68570_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | GRÜNENTHAL PHARMA S.A. | 2007-03-05 | 1 | 1 | 1 | 2007-03-05 | 2007-03-05 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 658669 | 68570 | ADOLONTA RETARD 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA | ADOLONTA RETARD 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA , 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68570/68570_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68570/68570_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | GRÜNENTHAL PHARMA S.A. | 2007-03-05 | 1 | 1 | 1 | 2007-03-05 | 2007-03-05 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 659012 | 68776 | OMEPRAZOL KRKA 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL KRKA 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68776/68776_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68776/68776_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2007-05-09 | 1 | 1 | 1 | 2007-05-09 | 2007-05-09 | 1 | 2014-05-31 | View Edit Delete | ||||||||||||
| 659103 | 68827 | PERINDOPRIL KRKA 4 mg COMPRIMIDOS EFG | PERINDOPRIL KRKA 4 mg COMPRIMIDOS EFG , 30 comprimidos | 4 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68827/68827_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68827/68827_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2007-06-05 | 1 | 1 | 1 | 2007-06-05 | 2007-06-05 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659680 | 62102 | STOPCOLD 5 mg/120 mg COMPRIMIDOS DE LIBERACION PROLONGADA | STOPCOLD 5 mg/120 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 20 comprimidos | 5 mg/120 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62102/62102_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62102/62102_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21333 | UCB PHARMA S.A. | 1998-07-01 | 1 | 1 | 1 | 1998-07-01 | 1998-07-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 660013 | 69345 | VALS 320 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | VALS 320 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 320 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69345/69345_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69345/69345_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2007-10-22 | 1 | 1 | 1 | 2007-10-22 | 2007-10-22 | 0 | 2011-10-17 | View Edit Delete | ||||||||||||
| 658929 | 68732 | OLANZAPINA QUALIGEN 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 2,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68732/68732_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68732/68732_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-30 | 1 | 1 | 1 | 2007-04-30 | 2007-04-30 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658931 | 68733 | OLANZAPINA QUALIGEN 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68733/68733_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68733/68733_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-27 | 1 | 1 | 1 | 2007-04-27 | 2007-04-27 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658932 | 68734 | OLANZAPINA QUALIGEN 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 7,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68734/68734_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68734/68734_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-30 | 1 | 1 | 1 | 2007-04-30 | 2007-04-30 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658933 | 68735 | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68735/68735_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68735/68735_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-27 | 1 | 1 | 1 | 2007-04-27 | 2007-04-27 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658934 | 68735 | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68735/68735_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68735/68735_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-27 | 1 | 1 | 1 | 2007-04-27 | 2007-04-27 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659212 | 68891 | ACIDO ALENDRONICO SEMANAL QUALIGEN 70 mg COMPRIMIDOS EFG | ACIDO ALENDRONICO SEMANAL QUALIGEN 70 mg COMPRIMIDOS EFG, 4 comprimidos | 70 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68891/68891_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68891/68891_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-05 | 1 | 1 | 1 | 2007-06-05 | 2007-06-05 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659361 | 68990 | ARENBIL 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 2,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68990/68990_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68990/68990_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659362 | 68991 | ARENBIL 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68991/68991_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68991/68991_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659363 | 68992 | ARENBIL 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 7,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68992/68992_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68992/68992_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659364 | 68993 | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68993/68993_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68993/68993_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659365 | 68993 | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68993/68993_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68993/68993_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659414 | 69021 | FORTASEC PLUS 2 mg/ 125 mg COMPRIMIDOS | FORTASEC PLUS 2 mg/ 125 mg COMPRIMIDOS , 12 comprimidos | 2 mg/125 mg | 5 | 12 | 10 | 12 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69021/69021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69021/69021_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | JNTL CONSUMER HEALTH (SPAIN) S.L. | 2007-07-11 | 1 | 1 | 1 | 2007-07-11 | 2007-07-11 | 1 | 2012-06-18 | View Edit Delete |
Page 147 of 1036, showing 20 records out of 20709 total, starting on record 2921, ending on 2940